News - UF Innovate

AGTC Announces Positive Three-Month Interim Results From Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa

UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today reported positive three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP).

UF Neuroscience Students Lead Creation of New Mouse Model for Alzheimer’s Research

A research team led by University of Florida neuroscience graduate students has devised a new mouse model to study the protein tau, which can abnormally accumulate inside neurons and is associated with Alzheimer’s disease and related dementias.

UF First Among US Public Universities in Tech Transfer for Economic Return

The University of Florida ranks first among public universities and second nationwide in a new report that evaluates which U.S. universities are best at moving new discoveries from the lab and into the real world through research commercialization and STEM graduates.

UF Study: Post-COVID Mortality Risk May Be Caused by Effects of High Inflammation During Illness

A University of Florida study sheds new light on the reason people who recover from a bout of severe COVID-19 are still at increased risk for death in the year after their recovery. The culprit may be high levels of inflammation during the initial illness.

Cannabix Technologies Correlates THC in Breath and Blood Using Proprietary Sample Collection and Analysis Hardware in Experimental Study

UF startup Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports it has successfully tested a supplemental version of its FAIMS technology for detection of ∆9-tetrahydrocannabinol (“THC”) and related analytes in human breath in an independent experimental study.

Research to Renewal: Advancing University Tech Transfer

The American research university is a unique institution that much of the world has long tried to emulate. Many times under-appreciated in the U.S., research universities are one of the most important knowledge assets of cities and states for economic development purposes. These universities influence the economic prospects of their regions and the nation overall in multiple ways. That said, ranking overall in second place, the University of Florida is the top public university on this list.

UF Ecologist Robert D. Holt Elected to the National Academy of Sciences

Robert D. Holt of the University of Florida Department of Biology has been elected to the National Academy of Sciences (NAS), joining the ranks of leading scientists recognized for their distinguished achievements in research.

UF Scripps Researcher’s Drug-Discovery Method Shows Promise Against Aggressive Breast Cancer

UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA. Until now, RNA has been an elusive target for drug discovery. Discoveries made by Disney and his collaborators have rewritten that dogma.

A First: Scientists Grow Plants in Soil From the Moon

Scientists have grown plants in soil from the moon, a first in human history and a milestone in lunar and space exploration. In a new paper published in the journal “Communications Biology,” University of Florida researchers showed that plants can successfully sprout and grow in lunar soil. Their study also investigated how plants respond biologically to the moon’s soil, also known as lunar regolith, which is radically different from soil found on Earth.

CITI Program and Biotility at UF Announce Partnership

The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility’s biotech training courses on CITI Program’s learning platform.

UF News